Implication of NPM1 phosphorylation and preclinical evaluation of the nucleoprotein antagonist N6L in prostate cancer.
Destouches D, Sader M, Terry S, Marchand C, Maillé P, Soyeux P, Carpentier G, Semprez F, Céraline J, Allory Y, Courty J, De La Taille A, Vacherot F.
Destouches D, et al. Among authors: de la taille a.
Oncotarget. 2016 Oct 25;7(43):69397-69411. doi: 10.18632/oncotarget.8043.
Oncotarget. 2016.
PMID: 26993766
Free PMC article.